Therapeutic drug monitoring for everolimus in heart transplant recipients: flawed model or a model for future use?
Starling
Randall C
RC
Kovarik
John M
JM
D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D016903:Drug Monitoring / Q000379:methods*; D004359:Drug Therapy, Combination; D000068338:Everolimus; D005919:Glomerular Filtration Rate; D016027:Heart Transplantation / Q000379:methods*; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008657:Metabolic Clearance Rate; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D012189:Retrospective Studies; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D013997:Time Factors; D016896:Treatment Outcome; D014463:Ultrasonography
D007166:Immunosuppressive Agents; D000068338:Everolimus; D009173:Mycophenolic Acid; D001379:Azathioprine; D020123:Sirolimus